Sigma Planning Corp Opgen Inc Transaction History

Sigma Planning Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	BUY	$0.72 - $1.11 $3,600 - $5,550	5,000 Added 40.0%	17,500 $13,000
Q4 2021 Feb 02, 2022	BUY	$1.0 - $2.94 $12,500 - $36,750	12,500 New	12,500 $13,000
Q3 2021 Oct 28, 2021	SELL	$2.18 - $3.58 $25,288 - $41,528	-11,600 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$1.95 - $2.8 $22,620 - $32,479	11,600 New	11,600 $26,000

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $38.7M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.